S. Burdach

770 total citations
35 papers, 549 citations indexed

About

S. Burdach is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Neurology. According to data from OpenAlex, S. Burdach has authored 35 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Immunology and 8 papers in Neurology. Recurrent topics in S. Burdach's work include Sarcoma Diagnosis and Treatment (8 papers), Neuroblastoma Research and Treatments (5 papers) and Immune Cell Function and Interaction (5 papers). S. Burdach is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Neuroblastoma Research and Treatments (5 papers) and Immune Cell Function and Interaction (5 papers). S. Burdach collaborates with scholars based in Germany, United States and Austria. S. Burdach's co-authors include Uta Dirksen, J. Treuner, Atsushi Miyajima, Ryuichi Nishinakamura, Robin Murray, Yoshihiro Morikawa, U. Göbel, Ewa Kościelniak, Gerd Horneff and J Hermann and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Pediatrics.

In The Last Decade

S. Burdach

35 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Burdach Germany 13 241 131 124 114 111 35 549
C. August Germany 12 107 0.4× 64 0.5× 80 0.6× 84 0.7× 28 0.3× 31 577
Hiroyuki Shichino Japan 14 65 0.3× 91 0.7× 62 0.5× 64 0.6× 133 1.2× 52 485
Xiaohui Zhao United States 12 84 0.3× 78 0.6× 124 1.0× 69 0.6× 45 0.4× 34 432
A Müftüoğlu Türkiye 15 426 1.8× 110 0.8× 33 0.3× 76 0.7× 81 0.7× 28 1.2k
Nozomi Iwanaga Japan 12 143 0.6× 67 0.5× 73 0.6× 181 1.6× 16 0.1× 47 611
Jan‐Erik Johansson Sweden 12 123 0.5× 173 1.3× 121 1.0× 72 0.6× 24 0.2× 29 456
Shay Shemesh United States 10 57 0.2× 164 1.3× 166 1.3× 81 0.7× 41 0.4× 24 578
Patricia Moya Spain 14 111 0.5× 108 0.8× 66 0.5× 101 0.9× 23 0.2× 65 565
Joyce Hui‐Yuen United States 13 100 0.4× 55 0.4× 122 1.0× 246 2.2× 19 0.2× 26 599
H. Chams Iran 13 159 0.7× 62 0.5× 31 0.3× 154 1.4× 52 0.5× 54 751

Countries citing papers authored by S. Burdach

Since Specialization
Citations

This map shows the geographic impact of S. Burdach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Burdach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Burdach more than expected).

Fields of papers citing papers by S. Burdach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Burdach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Burdach. The network helps show where S. Burdach may publish in the future.

Co-authorship network of co-authors of S. Burdach

This figure shows the co-authorship network connecting the top 25 collaborators of S. Burdach. A scholar is included among the top collaborators of S. Burdach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Burdach. S. Burdach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ladenstein, Ruth, D Valteau-Couanet, Evgenia Glogova, et al.. (2014). THE ROLE OF MEGATHERAPY (MGT) AND STEM CELL TRANSPLANTATION (SCT) IN HIGH RISK EWING TUMORS (ET): MORE THAN 30 YEARS OF EBMT ACTIVITY. mediaTUM (Technical University of Munich). 1 indexed citations
2.
Filipiak‐Pittroff, Birgit, et al.. (2013). Escalating Topotecan in Combination with Treosulfan has Acceptable Toxicity in Advanced Pediatric Sarcomas. Pediatric Hematology and Oncology. 30(4). 263–272. 1 indexed citations
3.
Uetz, Barbara, Angela Wawer, Michaela Nathrath, & S. Burdach. (2010). Intracranial Hemorrhage in Immune Thrombocytopenia (ITP): Fatal Course in Spite of Maximum Therapy. Klinische Pädiatrie. 222(6). 383–385. 1 indexed citations
4.
Warncke, Katharina, M. Steinborn, S. Burdach, & F. A. M. Baumeister. (2008). Akute Enzephalopathie bei Salmonellenenteritis. Klinische Pädiatrie. 220(2). 88–90. 1 indexed citations
5.
Foell, Juergen, Matthias Fischer, Michael Seibold, et al.. (2006). Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL. Pediatric Blood & Cancer. 49(6). 858–861. 20 indexed citations
6.
Baumann, Irith, Brigitte Strahm, Eva Bergstraesser, et al.. (2003). Immunosuppressive therapy for children with refractory anemia. mediaTUM (Technical University of Munich). 1 indexed citations
7.
Haase, Roland, et al.. (2003). Guillain-Barré-Syndrom als seltene Differenzialdiagnose respiratorischer Insuffizienz. Klinische Pädiatrie. 215(1). 30–34. 7 indexed citations
8.
Haase, Rocco, et al.. (2003). Die wachsende Bedeutung der pädiatrischen Intensivstation in der Behandlung onkologischer Patienten - Erfahrungen über 7 Jahre. Klinische Pädiatrie. 215(4). 234–240. 12 indexed citations
9.
Schmeling, Heinrike, Volker Stephan, S. Burdach, & Gerd Horneff. (2002). Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy. Zeitschrift für Rheumatologie. 61(2). 168–172. 20 indexed citations
10.
Dirksen, Uta, Tassilo Moritz, S. Burdach, Michael Flaßhove, & Helmut Hanenberg. (1999). Fanconi anemia and βc deficiency-associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by stem cell gene therapy but require different therapeutic approaches. Klinische Pädiatrie. 211(4). 329–335. 4 indexed citations
11.
Nürnberger, W., Halvard Bönig, S. Burdach, & U. Göbel. (1998). Tolerability of piperacillin/tazobactam in children and adolescents after high dose radio-/chemotherapy and autologous stem cell transplantation. Infection. 26(1). 65–67. 8 indexed citations
12.
Bönig, Halvard, et al.. (1998). Interaction Between Interleukin 10 and Interleukin 6 in Human B-Cell Differentiation. Immunological Investigations. 27(4-5). 267–280. 17 indexed citations
13.
Kościelniak, Ewa, T. Klingebiel, Christina Peters, et al.. (1997). Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.. Bone Marrow Transplantation. 19(3). 227–231. 69 indexed citations
14.
Nürnberger, W., et al.. (1997). Humoral coagulation and early complications after allogeneic bone marrow transplantation. Klinische Pädiatrie. 209(4). 209–215. 7 indexed citations
15.
Nishinakamura, Ryuichi, Uta Dirksen, Yoshihiro Morikawa, et al.. (1996). The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation.. The Journal of Experimental Medicine. 183(6). 2657–2662. 107 indexed citations
16.
17.
Berthold, Frank, S. Burdach, Bernhard Kremens, et al.. (1990). The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experience. Klinische Pädiatrie. 202(4). 262–269. 40 indexed citations
18.
Burdach, S., Lee Levitt, V. Wahn, & U. Göbel. (1989). Lymphokin-vermittelte Suppression der Erythropoese durch normale T-Lymphozyten und bei Retrovirus-assoziierter lymphoproliferativer Erkrankung. Oncology Research and Treatment. 12(3). 116–119. 1 indexed citations
19.
20.
Burdach, S., et al.. (1983). Prä- und retrorenale Neuroblastome ohne Nierenverlagerung . Klinische Pädiatrie. 195(1). 52–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. August Breakdown of academic impact, for papers by Hiroyuki Shichino Breakdown of academic impact, for papers by Xiaohui Zhao Breakdown of academic impact, for papers by A Müftüoğlu Breakdown of academic impact, for papers by Nozomi Iwanaga Breakdown of academic impact, for papers by Jan‐Erik Johansson Breakdown of academic impact, for papers by Shay Shemesh Breakdown of academic impact, for papers by Patricia Moya Breakdown of academic impact, for papers by Joyce Hui‐Yuen Breakdown of academic impact, for papers by H. Chams
Rankless by CCL
2026